• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Correlation of Thyroid Fine Needle Aspiration Biopsy With Histopathological Results.甲状腺细针穿刺活检与组织病理学结果的相关性
Cureus. 2023 May 17;15(5):e39130. doi: 10.7759/cureus.39130. eCollection 2023 May.
2
Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.贝塞斯达分类法是细针穿刺报告的重要指南,尤其对诊断甲状腺乳头状癌的侵袭性变体具有高度预测性。
Cytopathology. 2017 Aug;28(4):259-267. doi: 10.1111/cyt.12384. Epub 2016 Sep 25.
3
Fine needle aspiration and the Bethesda system: Correlation with histopathology in 1,228 surgical patients.细针抽吸与 Bethesda 系统:1228 例手术患者的组织病理学相关性。
Surgery. 2021 Nov;170(5):1364-1368. doi: 10.1016/j.surg.2021.05.016. Epub 2021 Jun 13.
4
Cytopathology-histopathology correlation and the effect of nodule diameter on diagnostic performance in patients undergoing thyroid fine-needle aspiration biopsy.细胞学-组织病理学相关性及结节直径对甲状腺细针抽吸活检患者诊断性能的影响。
J Cancer Res Ther. 2020 Dec;16(Supplement):S53-S58. doi: 10.4103/jcrt.JCRT_219_18.
5
Fine needle aspiration biopsy of thyroid nodules: cytologic and histopathologic correlation of 1096 patients.甲状腺结节细针穿刺活检:1096例患者的细胞学与组织病理学相关性研究
Int J Clin Exp Pathol. 2015 Nov 1;8(11):14800-5. eCollection 2015.
6
Thyroid Nodules Cytopathology Applying the Bethesda System with Histopathological Correlation.甲状腺结节细胞病理学:应用贝塞斯达系统并与组织病理学相关联
Saudi J Med Med Sci. 2018 Sep-Dec;6(3):143-148. doi: 10.4103/sjmms.sjmms_178_17. Epub 2018 Aug 14.
7
Diagnostic accuracy of fine needle aspiration biopsy versus postoperative histopathology for diagnosing thyroid malignancy.细针抽吸活检与术后组织病理学诊断甲状腺恶性肿瘤的诊断准确性。
Endocrinol Diabetes Metab. 2022 Nov;5(6):e373. doi: 10.1002/edm2.373. Epub 2022 Sep 23.
8
The rational use of fine needle aspiration biopsy (FNAB) in diagnosing thyroid nodules.细针穿刺活检(FNAB)在甲状腺结节诊断中的合理应用。
Minerva Endocrinol. 2006 Jun;31(2):159-72.
9
Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.Bethesda III 和 IV 甲状腺结节的恶性率:细针穿刺细胞学与组织病理学相关性的回顾性研究。
BMC Endocr Disord. 2020 Apr 15;20(1):48. doi: 10.1186/s12902-020-0530-9.
10
False-negative results with the Bethesda System of reporting thyroid cytopathology: predictors of malignancy in thyroid nodules classified as benign by cytopathologic evaluation.甲状腺细胞病理学报告的贝塞斯达系统中的假阴性结果:经细胞病理学评估分类为良性的甲状腺结节的恶性预测因素。
Am Surg. 2014 Aug;80(8):811-6.

本文引用的文献

1
The Prevalence of Thyroid Papillary Microcarcinoma in Patients With Benign Thyroid Fine Needle Aspiration.良性甲状腺细针穿刺患者中甲状腺微小乳头状癌的患病率
Cureus. 2020 Dec 1;12(12):e11820. doi: 10.7759/cureus.11820.
2
Thyroid Nodules Cytopathology Applying the Bethesda System with Histopathological Correlation.甲状腺结节细胞病理学:应用贝塞斯达系统并与组织病理学相关联
Saudi J Med Med Sci. 2018 Sep-Dec;6(3):143-148. doi: 10.4103/sjmms.sjmms_178_17. Epub 2018 Aug 14.
3
Evolving Understanding of the Epidemiology of Thyroid Cancer.甲状腺癌流行病学认识的演变。
Endocrinol Metab Clin North Am. 2019 Mar;48(1):23-35. doi: 10.1016/j.ecl.2018.10.002. Epub 2018 Dec 23.
4
The 2017 Bethesda System for Reporting Thyroid Cytopathology.2017 年甲状腺细胞病理学报告的贝塞斯达系统。
Thyroid. 2017 Nov;27(11):1341-1346. doi: 10.1089/thy.2017.0500.
5
Thyroid nodule update on diagnosis and management.甲状腺结节诊断与管理的最新进展
Clin Diabetes Endocrinol. 2016 Oct 3;2:17. doi: 10.1186/s40842-016-0035-7. eCollection 2016.
6
Ultrasound-guided core needle biopsy for differential diagnosis of thyroid nodules: A systematic review and meta-analysis.超声引导下粗针穿刺活检用于甲状腺结节的鉴别诊断:一项系统评价和Meta分析
Mol Clin Oncol. 2017 Jun;6(6):825-832. doi: 10.3892/mco.2017.1246. Epub 2017 May 8.
7
Clinical and histopathological characteristics of patients with incidental and nonincidental thyroid cancer.偶发性和非偶发性甲状腺癌患者的临床及组织病理学特征
Arch Med Sci. 2017 Mar 1;13(2):390-395. doi: 10.5114/aoms.2016.59579. Epub 2016 Apr 27.
8
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家310种疾病和损伤的发病率、患病率及伤残调整生命年:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1545-1602. doi: 10.1016/S0140-6736(16)31678-6.
9
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
10
Guidelines for the management of thyroid cancer.甲状腺癌管理指南。
Clin Endocrinol (Oxf). 2014 Jul;81 Suppl 1:1-122. doi: 10.1111/cen.12515.

甲状腺细针穿刺活检与组织病理学结果的相关性

Correlation of Thyroid Fine Needle Aspiration Biopsy With Histopathological Results.

作者信息

Durgun Cemalettin

机构信息

General Surgery, Memorial Dicle Hospital, Diyarbakır, TUR.

出版信息

Cureus. 2023 May 17;15(5):e39130. doi: 10.7759/cureus.39130. eCollection 2023 May.

DOI:10.7759/cureus.39130
PMID:37378189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10292013/
Abstract

Introduction Fine needle aspiration biopsy (FNAB) is an effective method used in the differential diagnosis of thyroid nodules. The Bethesda system has contributed to the determination of clinical approaches by bringing standardization to cytopathology reporting. However, the rate of cytological-histological incompatibility varies between 10% and 30%. Results differ according to clinics in the literature. These results create a need to reevaluate the efficacy and safety of fine needle aspiration biopsy. In this study, we aimed to evaluate the diagnostic accuracy of FNAB of thyroid nodules by correlating the cytopathology results of FNAB with the results of postoperative histopathology. Methods In this retrospective study, thyroid FNAB results and postoperative histopathology results of patients who underwent thyroidectomy operations in our clinic between January 2018 and December 2021 were compared. Accuracy, sensitivity (Sn), specificity (Sp), positive predictive value (PPV), negative predictive value (NPV), false positive rate (FPR), and false negative rate (FNR) were calculated. Cases with nondiagnostic FNAB results were excluded from the calculations. FNAB results with a follicular neoplasm/suspicious for a follicular neoplasm (FN/SFN) and suspicious for malignancy were included in the malignant group. Results A total of 304 patients were included in the study. The male/female ratio was 1:3.3. As a result of the study, malignancy was detected histopathologically in 47 (15.46%) patients. The commonest malignancy detected was papillary carcinoma. According to the Bethesda system, the results were evaluated in six categories. The incidence of malignancy in the Bethesda categories were 0%, 4%, 40%, 69.2%, 100%, and 100%, respectively. Accordingly, the specificity and sensitivity of FNAB for detecting malignancy were 98.7% and 66.6%, respectively. The accuracy was 93.5%. The false positive rate, false negative rate, positive predictive value, and negative predictive value were 1.20%, 33.3%, 91.4%, and 93.8%, respectively. Conclusion Thyroid FNAB is an effective method used with satisfactory reliability in the differential diagnosis of malignancies of thyroid nodules. Still, it has some limitations. This article demonstrates higher rates of malignancy in Bethesda categories III and IV. Therefore, clinical approaches are gaining importance in these categories.

摘要

引言 细针穿刺活检(FNAB)是用于甲状腺结节鉴别诊断的一种有效方法。贝塞斯达系统通过使细胞病理学报告标准化,为临床方法的确定做出了贡献。然而,细胞组织学不匹配率在10%至30%之间。文献中的结果因临床机构而异。这些结果使得有必要重新评估细针穿刺活检的有效性和安全性。在本研究中,我们旨在通过将FNAB的细胞病理学结果与术后组织病理学结果相关联,评估甲状腺结节FNAB的诊断准确性。

方法 在这项回顾性研究中,比较了2018年1月至2021年12月期间在我们诊所接受甲状腺切除术的患者的甲状腺FNAB结果和术后组织病理学结果。计算了准确性、敏感性(Sn)、特异性(Sp)、阳性预测值(PPV)、阴性预测值(NPV)、假阳性率(FPR)和假阴性率(FNR)。FNAB结果为非诊断性的病例被排除在计算之外。FNAB结果为滤泡性肿瘤/可疑滤泡性肿瘤(FN/SFN)和可疑恶性的病例被纳入恶性组。

结果 共有304例患者纳入研究。男女比例为1:3.3。研究结果显示,47例(15.46%)患者经组织病理学检测为恶性。最常见的恶性肿瘤是乳头状癌。根据贝塞斯达系统,结果分为六类进行评估。贝塞斯达分类中的恶性发生率分别为0%、4%、40%、69.2%、100%和100%。据此,FNAB检测恶性肿瘤的特异性和敏感性分别为98.7%和66.6%。准确性为93.5%。假阳性率、假阴性率、阳性预测值和阴性预测值分别为1.20%、33.3%、91.4%和93.8%。

结论 甲状腺FNAB是甲状腺结节恶性肿瘤鉴别诊断中一种可靠性令人满意的有效方法。不过,它仍有一些局限性。本文显示贝塞斯达分类III和IV中的恶性率较高。因此,这些分类中的临床方法正变得越来越重要。